BLRX Cổ tức: BioLineRx Ltd. Cảnh báo về tỷ suất sinh lời



Cổ tức

BLRX Cổ tức

BioLineRx Ltd.

$3.1

-7.46%

$-0.25

Khi đóng cửa: May 07, 16:00:00 GMT-4

$3.1

Phiên sau giờ: May 07, 20:00:00 GMT-4

Tổng quan Dự báo Thu nhập Cổ tức Tài chính

Thống kê chính

Giá đóng cửa trước

$3.35

Giá mở cửa

$3.29

Phạm vi ngày

$3.1 - $3.33

Phạm vi 52 tuần

$2.15 - $7.77

Khối lượng

13.5K

Khối lượng trung bình

18.3K

Tỷ suất cổ tức

EPS (TTM)

0.00

Vốn hóa thị trường

$13.4M

BioLineRx Ltd. là gì?

BioLineRx Ltd. is a clinical stage biopharmaceutical company, which engages in the research and development of treatments that focus on cancer. The company is headquartered in Modiin, Central(Hamerkaz) and currently employs 24 full-time employees. The company went IPO on 2007-01-30. The firm is commited into in-license novel compounds, develop them through clinical stages, and then partner with pharmaceutical companies for further clinical development andcommercialization. The firm is commited into two projects: Motixafortide (BL-8040), which is a cancer therapy platform , and AGI-134, an immunotherapy treatment.